Filippo Belardelli

Filippo Belardelli's AcademicInfluence.com Rankings

Filippo Belardelli

Computer Science

#7615

World Rank

#8017

Historical Rank

Machine Learning

#2866

World Rank

#2902

Historical Rank

Artificial Intelligence

#3160

World Rank

#3207

Historical Rank

Database

#4665

World Rank

#4846

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Filippo Belardelli's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Filippo Belardelli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Filippo Belardelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. (2001) (1016)
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (2014) (746)
Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice (2000) (720)
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer (2013) (696)
Type I interferons produced by dendritic cells promote their phenotypic and functional activation. (2002) (533)
Role of interferons and other cytokines in the regulation of the immune response (1995) (462)
ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α+ Dendritic Cells (2002) (455)
IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation1 (2001) (447)
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. (2004) (394)
The neglected role of type I interferon in the T-cell response: implications for its clinical use. (1996) (339)
Interferon-alpha in tumor immunity and immunotherapy. (2002) (334)
Cytokines as a link between innate and adaptive antitumor immunity. (2002) (317)
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis. (2011) (286)
Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. (2001) (277)
Cyclophosphamide Enhances the Antitumor Efficacy of Adoptively Transferred Immune Cells through the Induction of Cytokine Expression, B-Cell and T-Cell Homeostatic Proliferation, and Specific Tumor Infiltration (2007) (242)
Type I IFN as a Natural Adjuvant for a Protective Immune Response: Lessons from the Influenza Vaccine Model1 (2002) (233)
A Contribution of Mouse Dendritic Cell–Derived IL-2 for NK Cell Activation (2004) (222)
Interferon-α and cancer : Mechanisms of action and new perspectives of clinical use (2007) (219)
IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. (1997) (219)
Reciprocal Activating Interaction Between Dendritic Cells and Pamidronate-Stimulated γδ T Cells: Role of CD86 and Inflammatory Cytokines1 (2005) (214)
Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer. (2000) (212)
Chimeric Plant Virus Particles as Immunogens for Inducing Murine and Human Immune Responses against Human Immunodeficiency Virus Type 1 (2001) (177)
Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response. (1999) (174)
European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk. (2015) (169)
Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. (1998) (166)
Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Type I IFN-Mediated Monocyte Differentiation into Dendritic Cells: Impairment of Functional Activities and Chemotaxis1 (2005) (165)
IFN-γ Expression in Macrophages and Its Possible Biological Significance (1998) (155)
IFN‐α‐conditioned dendritic cells are highly efficient in inducing cross‐priming CD8+ T cells against exogenous viral antigens (2006) (151)
Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. (2007) (150)
The HIV-1 vpr Protein Acts as a Negative Regulator of Apoptosis in a Human Lymphoblastoid T Cell Line: Possible Implications for the Pathogenesis of AIDS (1998) (148)
Potent Immune Response against HIV-1 and Protection from Virus Challenge in hu-PBL-SCID Mice Immunized with Inactivated Virus-pulsed Dendritic Cells Generated in the Presence of IFN-α (2003) (140)
Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach. (2000) (133)
IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing. (2012) (133)
Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus. (1984) (129)
Interferon gamma upregulates its own gene expression in mouse peritoneal macrophages (1994) (126)
Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. I. (1982) (124)
Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. (1998) (122)
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors. (2006) (122)
ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. (2004) (121)
Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. (2005) (120)
Human Immunodeficiency Virus Type 1 gp120 Induces Abnormal Maturation and Functional Alterations of Dendritic Cells: a Novel Mechanism for AIDS Pathogenesis (2004) (119)
Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation (2003) (118)
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. (1996) (116)
Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. (2013) (115)
Human intestinal lamina propria lymphocytes are naturally permissive to HIV‐1 infection (1999) (115)
Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity (2010) (112)
The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. (2002) (107)
Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming (2011) (102)
Chemotherapy enhances vaccine‐induced antitumor immunity in melanoma patients (2009) (102)
Role of Cross-Talk between IFN-α-Induced Monocyte-Derived Dendritic Cells and NK Cells in Priming CD8+ T Cell Responses against Human Tumor Antigens1 (2004) (101)
Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors (1983) (97)
Endogenous type I interferons as a defense against tumors. (2002) (92)
Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level. (2005) (91)
Effect Of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice (2004) (89)
Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages (1995) (88)
Antiviral activity of lactoferrin. (1998) (85)
IFN Regulatory Factor-1 Negatively Regulates CD4+CD25+ Regulatory T Cell Differentiation by Repressing Foxp3 Expression1 (2008) (83)
Type I IFN Protects Permissive Macrophages from Legionella pneumophila Infection through an IFN-γ-Independent Pathway1 (2004) (82)
Bacterial lipopolysaccharide and gamma interferon induce transcription of beta interferon mRNA and interferon secretion in murine macrophages (1989) (79)
APC Activation by IFN-α Decreases Regulatory T Cell and Enhances Th Cell Functions (2010) (79)
LOX-1 as a natural IFN-alpha-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells. (2010) (78)
IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment. (2004) (76)
Monocyte-Derived Dendritic Cells Generated After a Short-Term Culture with IFN-α and Granulocyte-Macrophage Colony-Stimulating Factor Stimulate a Potent Epstein-Barr Virus-Specific CD8+ T Cell Response1 (2003) (75)
HIV-1 gp120 Stimulates the Production of β-Chemokines in Human Peripheral Blood Monocytes Through a CD4-Independent Mechanism1 (2001) (75)
Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide. (2011) (74)
Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. (1993) (73)
Monocyte/macrophage‐derived CC chemokines and their modulation by HIV‐1 and cytokines: A complex network of interactions influencing viral replication and AIDS pathogenesis (2003) (73)
Combination strategies for enhancing the efficacy of immunotherapy in cancer patients (2010) (72)
Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes (2008) (72)
Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously (1983) (70)
Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications. (2000) (70)
Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication (1994) (70)
Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy (2013) (70)
IFN-gamma expression in macrophages and its possible biological significance. (1998) (68)
Dual Role of the HIV-1 Vpr Protein in the Modulation of the Apoptotic Response of T Cells1 (2000) (67)
Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages. (2008) (67)
Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells. (1999) (67)
A New Type I IFN‐Mediated Pathway for the Rapid Differentiation of Monocytes into Highly Active Dendritic Cells (2003) (65)
Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. II. Role of host mechanisms (1982) (64)
A Type I IFN-Dependent Pathway Induced by Schistosoma mansoni Eggs in Mouse Myeloid Dendritic Cells Generates an Inflammatory Signature1 (2004) (64)
IRF‐1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features (2006) (63)
Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages (1985) (62)
Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12 (2011) (62)
Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons. (1987) (61)
Dendritic cells and cytokines in immune rejection of cancer. (2008) (60)
Type I interferons as vaccine adjuvants against infectious diseases and cancer (2008) (59)
Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. (2003) (59)
Type I Interferons as Regulators of Human Antigen Presenting Cell Functions (2014) (58)
Inhibition of human immunodeficiency virus (HIV‐1) infection in human peripheral blood leucocytes‐SCID reconstituted mice by rapamycin (2009) (58)
IFN-alpha in the generation of dendritic cells for cancer immunotherapy. (2009) (58)
31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice. (1986) (58)
The induction of in vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice. (1998) (56)
Human Immunodeficiency Virus Type 1 Strains R5 and X4 Induce Different Pathogenic Effects in hu-PBL-SCID Mice, Depending on the State of Activation/Differentiation of Human Target Cells at the Time of Primary Infection (1999) (55)
Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. (2004) (55)
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications (2019) (54)
Adoptive transfer of an anti‐MART‐127–35‐specific CD8+ T cell clone leads to immunoselection of human melanoma antigen‐loss variants in SCID mice (2003) (54)
Human Immunodeficiency Virus Type 1 gp120 and Other Activation Stimuli Are Highly Effective in Triggering Alpha Interferon and CC Chemokine Production in Circulating Plasmacytoid but Not Myeloid Dendritic Cells (2005) (54)
Inhibition of transcription and translation of globin messenger RNA in dimethyl sulfoxide-stimulated Friend erythroleukemic cells treated with interferon. (1977) (53)
IFN‐α and IL‐18 exert opposite regulatory effects on the IL‐12 receptor expression and IL‐12‐induced IFN‐γ production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages (2000) (52)
Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of friend erythroleukemia cells (1988) (52)
Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients. (2010) (51)
Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice. (1987) (50)
High-affinity binding of 125I-labeled mouse interferon to a specific cell surface receptor. IV. Mouse gamma interferon and cholera toxin do not compete for the common receptor site of alpha / beta interferon. (1982) (49)
IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity. (2011) (49)
Interferon inhibits dimethyl sulphoxide-induced erythroid differentiation of Friend leukaemia cells (1977) (49)
IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment. (2012) (49)
Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides (2001) (48)
2-5A synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with alpha/beta interferon despite the presence of high-affinity interferon receptor sites. (1983) (48)
T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells (1996) (47)
Impaired myelopoiesis in mice devoid of interferon regulatory factor 1 (2004) (47)
Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production (1990) (47)
Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy (2012) (47)
Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice. (2004) (46)
A multidisciplinary study using in vivo tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cells (2014) (44)
Loss of Type I IFN Receptors and Impaired IFN Responsiveness During Terminal Maturation of Monocyte-Derived Human Dendritic Cells1 (2002) (44)
Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus. (2006) (44)
Interleukin‐1β induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti‐tumor effects of tumor necrosis factor α or β (1989) (43)
Biologic and biochemical differences between in vitro and in vivo passaged friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize (1984) (43)
Inhibition of animal virus production by means of translation inhibitors unable to penetrate normal cells. (1980) (43)
Type I IFN regulate DC turnover in vivo (2009) (43)
Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir. (1996) (43)
Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice (2003) (42)
IFN‐α1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice (1995) (42)
Mouse peritoneal cells confer an antiviral state on mouse cell monolayers: role of interferon (1986) (42)
Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases (1990) (42)
Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages (2007) (41)
Role of type I interferon in inducing a protective immune response: perspectives for clinical applications. (2015) (41)
IFN-beta selectively down-regulates transferrin receptor expression in human peripheral blood macrophages by a post-translational mechanism. (1995) (40)
Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells. (1993) (40)
Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8 (1997) (40)
Immunomodulatory effects of the HIV-1 gp120 protein on antigen presenting cells: implications for AIDS pathogenesis. (2004) (39)
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy (2017) (39)
Modulations of glycerophosphorylcholine and phosphorylcholine in Friend erythroleukemia cells upon in vitro‐induced erythroid differentiation: a 31P NMR study (1984) (39)
Anti‐tumor effects of interleukin‐2 and interleukin‐1 in mice transplanted with different syngeneic tumors (1989) (39)
IRF‐4 expression in the human myeloid lineage: up‐regulation during dendritic cell differentiation and inhibition by 1α,25‐dihydroxyvitamin D3 (2005) (38)
Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice (1991) (38)
International Meeting on Cancer Vaccines (2004) (38)
The biological relevance of polykaryons in the immune response. (1997) (37)
Interferon (IFN)-β Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-α: Differential Effects on Tumorigenicity and Host Response (1999) (36)
Interferon-α as antiviral and antitumor vaccine adjuvants: mechanisms of action and response signature. (2012) (36)
Cytokines as natural adjuvants for vaccines: where are we now? (2002) (36)
Regulation of chemokine/cytokine network during in vitro differentiation and HIV‐1 infection of human monocytes: possible importance in the pathogenesis of AIDS (2000) (36)
Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice (1988) (35)
Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial. (2009) (35)
IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use (2011) (33)
Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. V. Comparisons with the action of tumor necrosis factor (1986) (33)
Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide (2018) (32)
CD2+/CD14+ monocytes rapidly differentiate into CD83+ dendritic cells (2003) (31)
Advances in the Use of Dendritic Cells and New Adjuvants for the Development of Therapeutic Vaccines (2003) (31)
Induction of cytokines by HIV‐1 and its gp120 protein in human peripheral blood monocyte/macrophages and modulation of cytokine response during differentiation (1997) (30)
Translational research on advanced therapies. (2011) (30)
Anti‐tumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. IV. Definition of optimal treatment regimens (1986) (30)
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma (2015) (29)
Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response. (2003) (29)
IL‐2 induces expression and secretion of IFN‐γ in murine peritoneal macrophages (2005) (28)
Persistent infection of normal mice with human immunodeficiency virus (1992) (28)
Induction of relA(p65) and I kappa B alpha subunit expression during differentiation of human peripheral blood monocytes to macrophages. (1997) (28)
ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells. (2006) (28)
Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha (2000) (28)
Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells (2018) (27)
Epstein‐Barr virus infection induces miR‐21 in terminally differentiated malignant B cells (2015) (27)
Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon. (1987) (27)
Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells. (2012) (27)
Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-α and HSVtk: perspectives for the generation of cancer vaccines (1997) (27)
Interaction of IFN α/β with host cells essential to the early inhibition of friend erythroleukemia visceral metastases in mice (1994) (27)
Tumor necrosis factor α induces early morphologic and metabolic alterations in friend leukemia cell tumors and fibrosarcomas in mice (1988) (27)
IFN‐α and Novel Strategies of Combination Therapy for Cancer (2007) (26)
THE SCID MOUSE REACTION TO HUMAN PERIPHERAL BLOOD MONONUCLEAR LEUKOCYTE ENGRAFTMENT: NEUTROPHIL RECRUITMENT INDUCED EXPRESSION OF A WIDE SPECTRUM OF MURINE CYTOKINES AND MOUSE LEUKOPOIESIS, INCLUDING THYMIC DIFFERENTIATION (1995) (25)
IFN-beta stimulates the production of beta-chemokines in human peripheral blood monocytes. Importance of macrophage differentiation. (2002) (25)
A good manufacturing practice method to ex vivo expand natural killer cells for clinical use. (2015) (25)
The essential role of endogenous IFN α/β in the anti‐metastatic action of sensitized T lymphocytes in mice injected with friend erythroleukemia cells (1995) (25)
Biologic and biochemical differences between in vitro and in vivo passaged friend erythroleukemia cells. II. Changes in cell surface glycoproteins associated with a highly malignant phenotype (1984) (25)
CC chemokine ligand 2 down-modulation by selected Toll-like receptor agonist combinations contributes to T helper 1 polarization in human dendritic cells. (2009) (24)
HIV-1 gp120 Stimulates the Production ofb-Chemokines in Human Peripheral Blood Monocytes Through a CD4-Independent Mechanism (2001) (24)
Antitumor activity of recombinant adenoviral vectors expressing murine IFN-α in mice injected with metastatic IFN-resistant tumor cells (2001) (24)
Induction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 in human monocytes/macrophages: requirement of gamma interferon for IL-12 secretion (1996) (23)
Cholera toxin and its B subunit inhibit interferon effects on virus production and erythroid differentiation of Friend leukemia cells. (1980) (23)
Role of endogenous interferon‐β in the restriction of HIV replication in human monocyte/macrophages (1994) (23)
Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function. (2002) (22)
Effectiveness of Mouse Interferon α/β Compared to Single-Agent Chemotherapy in Increasing Survival Time of Mice After Intravenous Inoculation of Friend Erythroleukemial Cells (1988) (22)
IFN-α Regulates Blimp-1 Expression via miR-23a and miR-125b in Both Monocytes-Derived DC and pDC (2013) (22)
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial (2019) (21)
Anti‐tumor effects of interferon in mice injected with interferonsensitive and interferon‐resistant friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases (1987) (21)
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individuals. (2008) (21)
Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression. (1994) (21)
Inhibition of the constitutive and induced IFN-beta production by IL-4 and IL-10 in murine peritoneal macrophages. (2000) (21)
Post‐translational up‐regulation of the cell surface‐associated α component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon (1997) (20)
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer (2016) (20)
Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN α/β therapy of friend erythroleukemia visceral metastases (1993) (19)
The HIV-1 vpr protein induces anoikis-resistance by modulating cell adhesion process and microfilament system assembly (2000) (19)
NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients (2016) (19)
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic? (2020) (19)
Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments (2011) (18)
Treatment of severe combined immunodeficiency mice with anti-murine granulocyte monoclonal antibody improves human leukocyte xenotransplantation. (1998) (18)
Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice. (2005) (18)
U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies. (1997) (18)
IFN-alpha and novel strategies of combination therapy for cancer. (2007) (17)
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells (2017) (17)
Exploiting dendritic cells in the development of cancer vaccines (2013) (16)
Human immunodeficiency virus type 1 induces cellular polarization, intercellular adhesion molecule-1 redistribution, and multinucleated giant cell generation in human primary monocytes but not in monocyte-derived macrophages. (1996) (16)
Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action. (1992) (16)
Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells (2019) (16)
Posttranscriptional regulation of interferon mRNA levels in peritoneal macrophages (1991) (16)
Interferon-induced antiviral actions in Friend leukemia cells: role of membrane gangliosides. (1982) (15)
Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response. (1999) (15)
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine (2019) (15)
Opposite regulatory effects of IFN‐β and IL‐3 on C‐type lectin receptors, antigen uptake, and phagocytosis in human macrophages (2014) (14)
Type I interferons as regulators of the differentiation/activation of human dendritic cells: methods for the evaluation of IFN-induced effects. (2005) (14)
Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection. (2004) (14)
Dendritic Cell Activation RNA, or Lipopolysaccharide and Promotes Response to Type I IFN, Double-Stranded IL-15 Is Expressed by Dendritic Cells in (2001) (13)
Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells (1991) (13)
IL-2 induces expression and secretion of IFN-gamma in murine peritoneal macrophages. (2005) (13)
Efficient Stimulation of T Cell Responses by Human IFN-α–induced Dendritic Cells Does Not Require Toll-like Receptor Triggering (2008) (13)
Human Lymphoblastoid CD4+ T Cells Become Permissive to Macrophage-Tropic Strains of Human Immunodeficiency Virus Type 1 after Passage into Severe Combined Immunodeficient Mice through In Vivo Upregulation of CCR5: In Vivo Dynamics of CD4+ T-Cell Differentiation in Pathogenesis of AIDS (1998) (12)
Inhibitory Activity of Constitutive Nitric Oxide on the Expression of Alpha/Beta Interferon Genes in Murine Peritoneal Macrophages (1999) (12)
Local and Systemic Response of Mice to Interferon-α1 -Transfected Friend Leukemia Cells (1995) (12)
Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice. (1999) (12)
Selective alteration of the turnover of interferon beta mRNA in peritoneal macrophages from LPS-hyporesponsive mice and its role in the defective expression of spontaneous interferon. (1993) (12)
Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive Fas-mediated autocrine suicide of uninfected cells (2000) (11)
Induction of Both CD8+ and CD4+ T-Cell–Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1 (2008) (11)
Alterations of lipid composition in Friend leukemia cell tumors in mice treated with tumor necrosis factor‐α (1990) (11)
Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression. (1993) (11)
Activation of glycerophosphocholine phosphodiesterase in friend leukemia cells upon in-vitro induced erythroid differentiation. 31P and 1H NMR studies (1992) (11)
Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon. (2002) (11)
The European Research Infrastructures of the ESFRI Roadmap in Biological and Medical Sciences: status and perspectives. (2014) (10)
Effect of mouse interferon alpha/beta on the expression of H-2 (class I) antigens and on the levels of 2'-5' oligoadenylate synthetase activity in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice. (1987) (10)
Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production (1991) (10)
Potential for Differentiation, Virus Production, and Tumorigenicity in Murine Erythroleukemic Cells Treated with Interferon (1978) (10)
In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea? (2019) (9)
The Italian Hub of Population Biobanks as a potential tool for improving public health stewardship. (2013) (9)
The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells. (1995) (8)
Impairment of Human Immunodeficiency Virus Type 1 (HIV-1) Entry into Jurkat T Cells by Constitutive Expression of the HIV-1 Vpr Protein: Role of CD4 Down-Modulation (2000) (8)
Inhibition of Lung Colonisation of a Mouse Mammary Carcinoma by Therapeutic Vaccination with Interferon-α Gene-Transduced Tumor Cells (1998) (8)
Differentiation of monocyte‐derived dendritic cells is associated with upregulation and activation of Rac‐1 small GTPase (2006) (7)
IFN-alpha 1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice. (1995) (7)
Molecular mechanisms of action of interferons in the Friend virus-induced leukemia cell system. (1987) (7)
Type I Interferons as Joint Regulators of Tumor Growth and Obesity (2021) (7)
International Meeting “Immunotherapy of Cancer: Challenges and Needs” (2007) (7)
Interferon and Friend leukemia cells in culture. (1977) (6)
Interferon Regulatory Factor 8-Deficiency Determines Massive Neutrophil Recruitment but T Cell Defect in Fast Growing Granulomas during Tuberculosis (2013) (6)
Friend murine leukemia virus and spleen focus-forming virus expression in highly malignant interferon-sensitive and interferon-resistant Friend leukemia cells. (1986) (6)
Influence of the site of tumor growth on the capacity of a low tumorigenic line of Friend erythroleukemia cells to differentiate. (1991) (6)
Type I interferons induce peripheral T regulatory cell differentiation under tolerogenic conditions. (2020) (6)
Role of interferons in the restriction of HIV replication in human monocytes/macrophages. (1994) (6)
Murine interferon-α1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-α/β therapy (1999) (5)
Effects of Interferon on the Expression of Cellular and Integrated Viral Genes in Friend Erythroleukemic Cells (1979) (5)
Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice. (1994) (5)
Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring (2020) (5)
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study (2020) (5)
Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis (2016) (5)
Synergistic anti‐tumor effects of combined IL‐1/IFN‐α/β therapy in mice injected with met astatic friend erythroleukemia cells (1991) (5)
Role of endogenous alpha/beta interferon in the selection of virus nonproducer Friend leukemia cells after serial intraperitoneal passages in syngeneic mice (1988) (5)
Spin‐lattice relaxation in murine tumors after in vivo treatment with interferon α/β or tumor necrosis factor α (1992) (5)
MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68. (2011) (5)
Role of cytokines in GVL (ESb lymphoma) and GVHD after adoptive transfer of allogeneic T lymphocytes in mice. (1998) (4)
Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells. (1992) (4)
Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers. (2013) (4)
Concanavalin A-induced inhibition of abrin and ricin activity parallels with a decrease of the number of toxin-binding uptake-elution cycles. (1982) (4)
Studies on the mechanism of the interferon-mediated antiviral state to vesicular stomatitis virus in resting mouse peritoneal macrophages. (1989) (4)
Wheat germ agglutinin-binding protein changes in highly malignant Friend leukemia cells metastasizing to the liver (1988) (4)
Effects of different biological response modifiers on interferon expression in bacterial lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive mouse peritoneal macrophages. (1990) (4)
Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells. (1995) (3)
Biotherapy of Cancer: Break the Barriers to Foster Translation oF knowledge (2008) (3)
The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward (2008) (3)
Interferon 3/Upregulates Its Own Gene Expression in Mouse Peritoneal Macrophages By Paola Di Marzio, Patrizia Puddu, Lucia Conti, (1994) (3)
Tumour necrosis factor-alpha increases the sensitivity of human immunodeficiency virus (HIV)-infected monocytic U937 cells to the complement-dependent cytotoxicity of sera from HIV type 1-infected individuals; role of the gp120 protein. (1993) (3)
Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta. (1989) (3)
LOX-1 as natural IFN-α mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells (2009) (3)
Nuclear Magnetic Resonance Analysis of Tumor Necrosis Factor-induced Alterations of Phospholipid Metabolites and pH in Friend Leukemia Cell Tumors and Fibrosarcomas in Mice 1 (2006) (3)
The biology of dendritic cells and HIV infection (2007) (3)
Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19 (2021) (2)
TRAIN: Training through Research Application Italian Initiative (2011) (2)
Interferon-alpha/beta in virus-induced mouse mammary carcinogenesis: effects on the spontaneous process and on the progression of transplanted pre-neoplastic lesions. (1992) (2)
Development of a pilot project on data sharing among partners of the Italian Hub of Population Biobanks (HIBP): association between lipid profile and socio-demographic variables. (2014) (2)
Conference on cancer vaccines (2000) (2)
Application of OECI Accreditation Program to Cancer Institutes of the Alleanza Contro il Cancro Italian Network: A Special Project Supported by the Italian Ministry of Health (2015) (2)
Cytokines, dendritic cells and immunological rejection. (2008) (2)
Murine interferon-alpha1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy. (1999) (2)
Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models (2021) (2)
Interferon (IFN)- b Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN- a Differential Effects on Tumorigenicity and Host Response (1999) (2)
Chimeric Models of SCID Mice Transplanted with Human Cells: The Hu‐PBL‐SCID Mouse and Its Use in AIDS Research (2001) (2)
Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases. (1993) (2)
First International Workshop on Human/SCID Mouse Models. (2001) (2)
31 P Magnetic Resonance Studies of Cytokine-Induced Alterations in Tumor Cells Transplanted into Syngeneic Mice (1993) (2)
Spin-lattice relaxation in murine tumors after in vivo treatment with interferon alpha/beta or tumor necrosis factor alpha. (1992) (2)
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial (2021) (2)
Studies on the Expression of Spontaneous Interferon-Like Activity in Mouse Peritoneal Cells (1987) (1)
Synergistic anti-tumor effects of combined IL-1/IFN-alpha/beta therapy in mice injected with metastatic Friend erythroleukemia cells. (1991) (1)
Interferon‐α/β in virus‐induced mouse mammary carcinogenesis: Effects on the spontaneous process and on the progression of transplanted pre‐neoplastic lesions (1992) (1)
Interferons and dendritic cells (2007) (1)
Possible role of the Friend virus life cycle in differentiating Friend leukemia cells treated with interferon. (1979) (1)
Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells. (1988) (1)
immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages (2017) (1)
Dendritic cells as targets and tools in vaccines (2006) (1)
[Role of gangliosides in interferon and cell membrane interaction]. (1982) (1)
SCID Mice Transplanted With Human Cells as Small Animal Models in AIDS Research (2006) (1)
Microarray technologies in clinical oncology: potential and perspectives (2005) (1)
Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with thein vivo behaviour of tumor cells (1989) (1)
A semi-automatic web based tool for the selection of research projects reviewers (2014) (1)
Microarray analysis for monitoring the response to interferon (2005) (1)
Detection by 1H MRS of altered phosphatidylcholine metabolism in human ovarian cancer cells (2007) (1)
Erratum: Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin. (Clinical and Experimental Immunology (2009) 155 (28-34)) (2009) (0)
Conference on cancer vaccines. Abstract book (1999) (0)
Cross-Priming of Tumor Apoptotic Cells Leading to Dendritic Cells after Uptake + α Survival of CD8 Type I IFNs Control Antigen Retention and (2011) (0)
Mechanisms of Combined IL-1/IL-2 and IL-1/IFN Therapy in Mice Injected with Metastatic Tumor Cells (1992) (0)
151 Interferon regulatory factor-1 negatively regulates CD4+CD25+ regulatory T-cells by repressing FOXP3 (2008) (0)
IFN-Alpha as an adjuvant in cancer immunotherapy (2006) (0)
Spontaneous expression of interferon genes in murine peritoneal macrophages: modulation during the in vitro aging. (1992) (0)
European advanced translational research infrastructure in medicine (EATRIS) (2011) (0)
Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7–9, 2010 (2011) (0)
Combination of immunotherapy with chemotherapy to redirect the antitumor immune response: from preclinical studies to patients (2008) (0)
ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8 (cid:2) (cid:3) Dendritic Cells (2002) (0)
Interferon fundamentals: a tribute to the scientific vision of G B Rossi. Editorial. (2015) (0)
Cholera in Sardinia: imported infection or endemic focus? (1982) (0)
Implementation and use of the Hu-PBL-SCID mouse model for studies on the development od anti-HIV vaccines (2005) (0)
T cell homeostasis and memory (PP-059) (2010) (0)
Interferon and Tumor Necrosis Factor Alter the Phospholipid Metabolism in Friend Leukemia Cell Tumors in Mice (1987) (0)
Cytokines and their role in the activation of the immune response to tumors (1999) (0)
Personalized Immunotherapy in Follicular Lymphoma By Intranodal IFN-Dendritic-Cell Combined to Anti-CD20 Antibody (2016) (0)
Dendritic cells generated with type I IFN: potential advantages for their use in the development of therapeutic vaccines (2004) (0)
Enhancement of vaccine-mediated antitumor immunity in melanoma patients by dacarbazine treatment (2006) (0)
[Interferon: validity, risks, prospects of clinical use]. (1987) (0)
Interferon-alpha enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing and processing. (2011) (0)
Inflammatory Signature Myeloid Dendritic Cells Generates an Eggs in Mouse Schistosoma mansoni by A Type I IFN-Dependent Pathway Induced (2004) (0)
Studies of pathological and immunological alterations induced by coinfections with candida albicans or murine virus MHV-68 in CD4 transgenic mice injected with HIV-infected cells and new strategies for obtaining a productive HIV infection in mice (1999) (0)
Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants. (1991) (0)
Inhibition oftranscription andtranslation ofglobin messenger RNA indimethyl sulfoxide-stimul ated Friend erythroleukemic cells treated withinterferon (1977) (0)
Choline phospholipid metabolism in human ovarian tumor progression : a MRS study (2006) (0)
Detection by 1 H MRS of altered phosphatidylcholine metabolism in human ovarian cancer cells (2007) (0)
Corrigendum to “Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring” (2020) (0)
High Response Rate in Relapsed/Refractory Follicular Lymphoma Following Personalised Immunotherapy with Intranodal IFN-Alfa-Dendritic-Cell and Rituximab (2018) (0)
Monocytotoxic antibodies in HIV-infected persons. TNF-alpha treatment of U937 cells increases the complement dependent cytotoxicity. (1993) (0)
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008 (2009) (0)
Immunological relevance of the tumor associated antigen (TAA) COA-1 in colorectal cancer (CRC). (2006) (0)
Diversification of TCR repertoire in melanoma patients treated with chemotherapy before peptides-vaccination (41.19) (2009) (0)
2006 Extraordinary Oncology Programme. Art. 3 "National Support Network and International Cooperation (ISS for ACC)". 2008-2009 report on scientific activity. (2010) (0)
International Accreditation of Cancer Centres of Italian Network of Alleanza Contro il Cancro: Introductory Remarks (2015) (0)
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19–22, 2011: New perspectives in the immunotherapy of cancer (2012) (0)
Immunization of stage IV melanoma patients with MART-1 and GP100 peptides together with IFN-alpha as adjuvant results in an increased number of monocytes/dendritic cell precursors (2004) (0)
Adjuvants, Dendritic Cells, and Cytokines: Strategies for Enhancing Vaccine Efficacy (2007) (0)
CCL2 down-modulation by selected TLR agonist combinations contributes to Th1 polarization in human dendritic cells (2009) (0)
arbazine Treatment before Peptide Vaccination rges T-Cell Repertoire Diversity of Melan-A–Specific, (2010) (0)
PS2-001. Regulation of mannose receptor expression, phagocytosis and antigen processing in human macrophages: role of type I IFN and IL-3 (2011) (0)
Application of OECI accreditation program to cancer institutes of the Alleanza Contro il Cancro Italian Network: a special project supported by the Italian Ministry of Health. (2015) (0)
Partecipazione a ECRIN - European Clinical Research Infrastructures Network (2011) (0)
hu-SCID: A model for the evaluation of vaginal microbicides (2001) (0)
CD2+/CD14+ monocytes rapidly differentiate into CD83+ denditric cells in response to danger signals: role of type I IFN (2002) (0)
Correction: Interferon Regulatory Factor 8-Deficiency Determines Massive Neutrophil Recruitment but T Cell Defect in Fast Growing Granulomas during Tuberculosis (2013) (0)
International Accreditation of Cancer Centres of Italian Network of Alleanza contro il Cancro: introductory remarks. (2016) (0)
Antitumor response in mice transplanted with IFN-alpha producing tumor cells (1994) (0)
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5–7, 2012 (2013) (0)
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma (2015) (0)
Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1–3 October 2009 (2010) (0)
Corrigendum to “MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68” [Vaccine 29 (2011) 3935–3944] (2012) (0)
Cross-PrimingUptake of Tumor Apoptotic Cells Leading to Dendritic Cells after + a Survival of CD8 Type I IFNs Control Antigen Retention and (2011) (0)
INTRANODAL TREATMENT WITH IFNΑ‐DENDRITIC CELLS AND RITUXIMAB INDUCES SYSTEMIC CLINICAL RESPONSE AND ENDOGENOUS VACCINATION AGAINST FOLLICULAR LYMPHOMA: FINAL RESULT OF A PHASE I STUDY (2019) (0)
Expression of interferon genes in murine macrophages: Possible role of endogenous interferon in the modulation of cell differentiation (1991) (0)
Mechanism Monocytes Through a CD 4-Independent-Chemokines in Human Peripheral Blood β HIV-1 gp 120 Stimulates the Production of Gessani (2001) (0)
Choline phospholipid metabolism as source of new biomarker and therapeutic target in ovary cancer (2007) (0)
The "added value" of using hu-scid mouse models for studies on the pathogenesis, therapy and prophylaxis of HIV-1 infection" (1999) (0)
Perspectives in interferon and cytokine research. (1996) (0)
Cancer Therapy : Clinical Cyclophosphamide Induces a Type I Interferon – Associated Sterile In fl ammatory Response Signature in Cancer Patients ' Blood Cells : Implications for Cancer Chemoimmunotherapy (2013) (0)
Clinical trials using IFN-a as a vaccine adjuvant: new strategies for the molecolar monitoring of the immune response (2006) (0)
Reciprocal activating interaction between dendritic cells and aminobiphosphonates-stimulated T cells: role of CD86 and inflammatory cytokines (2009) (0)
Dendritic Cells Maturation of Monocyte-Derived Human IFN Responsiveness During Terminal Loss of Type I IFN Receptors and Impaired Belardelli and (2002) (0)
Inhibition by interferon (IFN) of the development of hepatic and splenic metastases in mice: role of host mechanisms (1990) (0)
Similarities and Dissimilarities in the Effects of Tumor Necrosis Factor and Interferon-α/β on Transplantable Tumors and on Suckling Mice (1988) (0)
This information is current as Cells Modulation of the Apoptotic Response of T Dual Role of the HIV-1 Vpr Protein in the Belardelli and (2000) (0)
Late abstracts 186–187 (2005) (0)
potent migratory and functional activities monocyte-derived dendritic cells : importance for the rapid acquisition of , and Th1 chemokines in type I IFN-induced β Expression (2001) (0)
Perspectives in interferon and cytokine research, Memorial day in honor of Professor Giovanni Battista Rossi. (1996) (0)
Vaccination of HU-PBL-SCID mice with human autologous dendritic cells pulsed with AT-2-inactivated HIV-1 induces neutralizing antibodies and virus-specific CTLs and confers protection from HIV-1 challenge (2002) (0)
Cryptic phenomena in the mechanism of action of antiviral drugs: study of immunomodulatory bystander effects in murine models (1999) (0)
Effects of cisplatin treatment on 1H MR spectral profiles of in vitro and in vivo ovarian cancer cells (2009) (0)
Langerhans cells and dermal dendritic cells ICSBP is critically involved in the normal development and trafficking of (2013) (0)
Combined Interleukin lÃŸ/Interleukin2 Treatment in Mice: Synergistic Myelostimulatory Activity and Protection against Cyclophosphamide-induced Myelosuppression1 (2006) (0)
IFN-gamma expression is positively regulated by IL-15 and IL-2 in mouse peritoneal macrophages (2002) (0)
[The interferon system]. (1987) (0)
Experimental design for the evaluation of the antitumor action of cytokines. (1990) (0)
Studies on the possible mechanisms of antitumor action of mouse interferons. (1987) (0)
[Effect of concanavalin A on the cellular interaction of abrin and ricin]. (1982) (0)
Inhibition of HIV-1 Infection in Hu–PBL–SCID Reconstituted Mice by Rapamacyn (2008) (0)
Membrane changes during tumor progression. Host control of metastatic spread. (1988) (0)
Decreased DTH response to recall antigens in mice injected with human immunodeficiency virus type 1-infected U937 cells and infected with Candida albicans. (1998) (0)
Extraordinary Oncology Research Programme 2006. Part 3 - "National network for solidarity and international collaboration (ISS for ACC)". Accounts of scientific activity (2007-2008), Rome, Italy, 9-10 February 2009. (2009) (0)
Cyclophosphamide Enhances theAntitumor Efficacy of Adoptively Transferred Immune Cells through the Induction of Cytokine Expression , B-Cell andT-Cell Homeostatic Proliferation , and SpecificTumor Infiltration (2007) (0)
Tumour necrosis factor- increases the sensitivity of human immunodeficiency virus (HIV)-infected monocytic U937 cells to the complement-dependent cytotoxicity of sera from HIV type 1-infected individuals; role of the gpl20 protein (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Filippo Belardelli?

Filippo Belardelli is affiliated with the following schools:

Filippo Belardelli's Academic­Influence.com Rankings

Filippo Belardelli's Degrees

Similar Degrees You Can Earn

Why Is Filippo Belardelli Influential?

Filippo Belardelli's Published Works

Published Works

What Schools Are Affiliated With Filippo Belardelli?

Filippo Belardelli's AcademicInfluence.com Rankings